D-1540-2022 Class I Terminated
FDA drug recall D-1540-2022 was initiated by Pfizer Inc. on August 22, 2022 and is designated Class I. Reason for recall: Presence of particulate matter The recall status is terminated (terminated June 30, 2025). Affected quantity: 5,390 vials.
Recall Details
- Product Type
- Drugs
- Report Date
- September 21, 2022
- Initiation Date
- August 22, 2022
- Termination Date
- June 30, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 5,390 vials
Product Description
PROPOFOL Injectable Emulsion, 1 g/100 mL (10 mg/mL), packaged in 100 mL glass fliptop vial (NDC 0409-4699-54) further packaged in a tray of 10 vials (NDC Carton: 0409-4699-24), Rx only, Distributed by Hospira, Inc., Lake Forest, IL 60045 USA
Reason for Recall
Presence of particulate matter
Distribution Pattern
USA Nationwide
Code Information
Lot#: EA7470, Exp 6/1/2023